DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients …

Positive results from the TROPION-Breast02 phase 3 trial showed DATROWAY® (datopotamab deruxtecan) demonstrated a ...
Japan Today

Obesity remains high in U.S., but more states are showing progress, a new report finds

For the first time in more than a decade, the number of states with rates of obesity of 35% or more has dropped, an encouraging sign that America's epidemic of excess weight might be improving. But ...